Marquette Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,012
| Closed | -$45.3K | – | 198 |
|
|
2023
Q4 | $45.3K | Hold |
6,012
| – | – | 0.01% | 141 |
|
|
2023
Q3 | $90.2K | Sell |
6,012
-6,127
| -50% | -$91.9K | 0.02% | 109 |
|
|
2023
Q2 | $193K | Hold |
12,139
| – | – | 0.05% | 81 |
|
|
2023
Q1 | $87.1K | Hold |
12,139
| – | – | 0.02% | 122 |
|
|
2022
Q4 | $70.3K | Buy |
12,139
+2,448
| +25% | +$14.2K | 0.02% | 137 |
|
|
2022
Q3 | $92K | Sell |
9,691
-3,586
| -27% | -$34K | 0.03% | 112 |
|
|
2022
Q2 | $159K | Buy |
13,277
+6,702
| +102% | +$80.3K | 0.05% | 91 |
|
|
2022
Q1 | $86K | Buy |
6,575
+1,175
| +22% | +$15.4K | 0.02% | 159 |
|
|
2021
Q4 | $95K | Buy |
5,400
+840
| +18% | +$14.8K | 0.02% | 154 |
|
|
2021
Q3 | $99K | Buy |
+4,560
| New | +$99K | 0.02% | 141 |
|
|
2017
Q4 | – | Sell |
-2,600
| Closed | -$95K | – | 64 |
|
|
2017
Q3 | $95K | Hold |
2,600
| – | – | 0.04% | 81 |
|
|
2017
Q2 | $65K | Buy |
2,600
+225
| +9% | +$5.63K | 0.03% | 84 |
|
|
2017
Q1 | $64K | Buy |
+2,375
| New | +$64K | 0.03% | 87 |
|